Report Detail

Request for Sample of this report

Pharma & Healthcare Global Type 1 Diabetes (T1D) Sales Market Report 2021

  • RnM3747706
    • |
  • 27 May, 2021
    • |
  • Global
    • |
  • 132 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

The global Type 1 Diabetes (T1D) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes (T1D) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs

Segment by Application
Children
Adults

The Type 1 Diabetes (T1D) market is analysed and market size information is provided by regions (countries). Segment by Application, the Type 1 Diabetes (T1D) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Novo Nordisk
Sanofi
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon
Astellas
Janssen
Bristol-Myers Squibb
Lexicon
Sanofi


1 Type 1 Diabetes (T1D) Market Overview

  • 1.1 Type 1 Diabetes (T1D) Product Scope
  • 1.2 Type 1 Diabetes (T1D) Segment by Type
    • 1.2.1 Global Type 1 Diabetes (T1D) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Rapid Acting Insulin Analogs
    • 1.2.3 Long Acting Insulin Analogs
    • 1.2.4 Premix Insulin Analogs
  • 1.3 Type 1 Diabetes (T1D) Segment by Application
    • 1.3.1 Global Type 1 Diabetes (T1D) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Children
    • 1.3.3 Adults
  • 1.4 Type 1 Diabetes (T1D) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Type 1 Diabetes (T1D) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Type 1 Diabetes (T1D) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Type 1 Diabetes (T1D) Price Trends (2016-2027)

2 Type 1 Diabetes (T1D) Estimates and Forecasts by Region

  • 2.1 Global Type 1 Diabetes (T1D) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Type 1 Diabetes (T1D) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Type 1 Diabetes (T1D) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Type 1 Diabetes (T1D) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Type 1 Diabetes (T1D) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.3 China Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.6 India Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)

3 Global Type 1 Diabetes (T1D) Competition Landscape by Players

  • 3.1 Global Top Type 1 Diabetes (T1D) Players by Sales (2016-2021)
  • 3.2 Global Top Type 1 Diabetes (T1D) Players by Revenue (2016-2021)
  • 3.3 Global Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Type 1 Diabetes (T1D) as of 2020)
  • 3.4 Global Type 1 Diabetes (T1D) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Type 1 Diabetes (T1D) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Type 1 Diabetes (T1D) Market Size by Type

  • 4.1 Global Type 1 Diabetes (T1D) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Type 1 Diabetes (T1D) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Type 1 Diabetes (T1D) Price by Type (2016-2021)
  • 4.2 Global Type 1 Diabetes (T1D) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Type 1 Diabetes (T1D) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Type 1 Diabetes (T1D) Price Forecast by Type (2022-2027)

5 Global Type 1 Diabetes (T1D) Market Size by Application

  • 5.1 Global Type 1 Diabetes (T1D) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Type 1 Diabetes (T1D) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Type 1 Diabetes (T1D) Price by Application (2016-2021)
  • 5.2 Global Type 1 Diabetes (T1D) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Type 1 Diabetes (T1D) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Type 1 Diabetes (T1D) Price Forecast by Application (2022-2027)

6 North America Type 1 Diabetes (T1D) Market Facts & Figures

  • 6.1 North America Type 1 Diabetes (T1D) Sales by Company
    • 6.1.1 North America Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 6.1.2 North America Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 6.2 North America Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 6.2.1 North America Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 6.3.1 North America Type 1 Diabetes (T1D) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Type 1 Diabetes (T1D) Sales Breakdown by Application (2022-2027)

7 Europe Type 1 Diabetes (T1D) Market Facts & Figures

  • 7.1 Europe Type 1 Diabetes (T1D) Sales by Company
    • 7.1.1 Europe Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 7.1.2 Europe Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 7.2 Europe Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 7.2.1 Europe Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)

8 China Type 1 Diabetes (T1D) Market Facts & Figures

  • 8.1 China Type 1 Diabetes (T1D) Sales by Company
    • 8.1.1 China Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 8.1.2 China Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 8.2 China Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 8.2.1 China Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 8.3 China Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 8.3.1 China 154 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 154 Sales Breakdown by Application (2022-2027)

9 Japan Type 1 Diabetes (T1D) Market Facts & Figures

  • 9.1 Japan Type 1 Diabetes (T1D) Sales by Company
    • 9.1.1 Japan Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 9.1.2 Japan Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 9.2 Japan Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 9.2.1 Japan Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Type 1 Diabetes (T1D) Market Facts & Figures

  • 10.1 Southeast Asia Type 1 Diabetes (T1D) Sales by Company
    • 10.1.1 Southeast Asia Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Type 1 Diabetes (T1D) Market Facts & Figures

  • 11.1 India Type 1 Diabetes (T1D) Sales by Company
    • 11.1.1 India Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 11.1.2 India Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 11.2 India Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 11.2.1 India Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 11.3 India Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 11.3.1 India Type 1 Diabetes (T1D) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Type 1 Diabetes (T1D) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Type 1 Diabetes (T1D) Business

  • 12.1 Novo Nordisk
    • 12.1.1 Novo Nordisk Corporation Information
    • 12.1.2 Novo Nordisk Business Overview
    • 12.1.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Novo Nordisk Type 1 Diabetes (T1D) Products Offered
    • 12.1.5 Novo Nordisk Recent Development
  • 12.2 Sanofi
    • 12.2.1 Sanofi Corporation Information
    • 12.2.2 Sanofi Business Overview
    • 12.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Sanofi Type 1 Diabetes (T1D) Products Offered
    • 12.2.5 Sanofi Recent Development
  • 12.3 Eli Lilly
    • 12.3.1 Eli Lilly Corporation Information
    • 12.3.2 Eli Lilly Business Overview
    • 12.3.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Eli Lilly Type 1 Diabetes (T1D) Products Offered
    • 12.3.5 Eli Lilly Recent Development
  • 12.4 Merck
    • 12.4.1 Merck Corporation Information
    • 12.4.2 Merck Business Overview
    • 12.4.3 Merck Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Merck Type 1 Diabetes (T1D) Products Offered
    • 12.4.5 Merck Recent Development
  • 12.5 Boehringer Ingelheim
    • 12.5.1 Boehringer Ingelheim Corporation Information
    • 12.5.2 Boehringer Ingelheim Business Overview
    • 12.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Products Offered
    • 12.5.5 Boehringer Ingelheim Recent Development
  • 12.6 Samsung Bioepis
    • 12.6.1 Samsung Bioepis Corporation Information
    • 12.6.2 Samsung Bioepis Business Overview
    • 12.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Samsung Bioepis Type 1 Diabetes (T1D) Products Offered
    • 12.6.5 Samsung Bioepis Recent Development
  • 12.7 Biocon
    • 12.7.1 Biocon Corporation Information
    • 12.7.2 Biocon Business Overview
    • 12.7.3 Biocon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Biocon Type 1 Diabetes (T1D) Products Offered
    • 12.7.5 Biocon Recent Development
  • 12.8 Astellas
    • 12.8.1 Astellas Corporation Information
    • 12.8.2 Astellas Business Overview
    • 12.8.3 Astellas Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Astellas Type 1 Diabetes (T1D) Products Offered
    • 12.8.5 Astellas Recent Development
  • 12.9 Janssen
    • 12.9.1 Janssen Corporation Information
    • 12.9.2 Janssen Business Overview
    • 12.9.3 Janssen Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Janssen Type 1 Diabetes (T1D) Products Offered
    • 12.9.5 Janssen Recent Development
  • 12.10 Bristol-Myers Squibb
    • 12.10.1 Bristol-Myers Squibb Corporation Information
    • 12.10.2 Bristol-Myers Squibb Business Overview
    • 12.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Products Offered
    • 12.10.5 Bristol-Myers Squibb Recent Development
  • 12.11 Lexicon
    • 12.11.1 Lexicon Corporation Information
    • 12.11.2 Lexicon Business Overview
    • 12.11.3 Lexicon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Lexicon Type 1 Diabetes (T1D) Products Offered
    • 12.11.5 Lexicon Recent Development
  • 12.12 Sanofi
    • 12.12.1 Sanofi Corporation Information
    • 12.12.2 Sanofi Business Overview
    • 12.12.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Sanofi Type 1 Diabetes (T1D) Products Offered
    • 12.12.5 Sanofi Recent Development

13 Type 1 Diabetes (T1D) Manufacturing Cost Analysis

  • 13.1 Type 1 Diabetes (T1D) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Type 1 Diabetes (T1D)
  • 13.4 Type 1 Diabetes (T1D) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Type 1 Diabetes (T1D) Distributors List
  • 14.3 Type 1 Diabetes (T1D) Customers

15 Market Dynamics

  • 15.1 Type 1 Diabetes (T1D) Market Trends
  • 15.2 Type 1 Diabetes (T1D) Drivers
  • 15.3 Type 1 Diabetes (T1D) Market Challenges
  • 15.4 Type 1 Diabetes (T1D) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Type 1 Diabetes (T1D). Industry analysis & Market Report on Type 1 Diabetes (T1D) is a syndicated market report, published as Global Type 1 Diabetes (T1D) Sales Market Report 2021. It is complete Research Study and Industry Analysis of Type 1 Diabetes (T1D) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,000.00
    		$6,000.00
    		$8,000.00
    		3,092.00
    		4,638.00
    		6,184.00
    		3,724.00
    		5,586.00
    		7,448.00
    		610,760.00
    		916,140.00
    		1,221,520.00
    		337,600.00
    		506,400.00
    		675,200.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo